Production of colony-stimulating factors (CSF) by lung tissue from rats injected by bacillus Calmette-Guérin (BCG) and the role of alveolar macrophages (AM) in this process was studied. Injection of BCG at 10, 100, or 1,000 mg/kg changed the CSF production by the lung in a time-dependent manner. Maximum stimulation was observed at 10 mg/kg and 3 days of interval between BCG injection and animal sacrifice. Longer periods or higher concentrations had no effect or actually depressed CSF production. BCG injection also changed the number of AM in a time- and dose-dependent manner. When AM from BCG-treated animals were lavaged out and the AM-depleted lung tissues were cultured, an increase in CSF production with respect to controls was observed at 10 mg/kg of BCG. On the other hand, in control animals removal of AM had no effect on CSF production by the lung. The results suggest that BCG treatment alters the number of AM and CSF production by the lung. AM, in BCG-injected animals, inhibit CSF production by the lung tissue while in non-injected animals they do not play any role in this process.

Keywords:
Bacillus Calmette-Guérin, Alveolar macrophages, Colony-stimulating factors
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.